Acute haemodynamic response in relation to plasma vardenafil concentrations in patients with pulmonary hypertension.
作者： Dan Henrohn , Anna Sandqvist , Mikael Hedeland , Hanna Egeröd , Ulf Bondesson
DOI: 10.1111/J.1365-2125.2012.04303.X
关键词:
摘要: AIMS To evaluate the acute haemodynamic effects of a single oral dose vardenafil and to study drug concentration in relation patients with pulmonary hypertension ( ...
sci-hub.se 参考文章(31)
K. F. Rabe, H. Tenor, G. Dent, C. Schudt, M. Nakashima, H. Magnussen, Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. American Journal of Physiology-lung Cellular and Molecular Physiology. ,vol. 266, ,(1994) , 10.1152/AJPLUNG.1994.266.5.L536
H A Toque, C E Teixeira, F B M Priviero, R P Morganti, E Antunes, G De Nucci, Vardenafil, but not sildenafil or tadalafil, has calcium-channel blocking activity in rabbit isolated pulmonary artery and human washed platelets British Journal of Pharmacology. ,vol. 154, pp. 787- 796 ,(2009) , 10.1038/BJP.2008.141
Zhi-Cheng Jing, Zai-Xin Yu, Jie-Yan Shen, Bing-Xiang Wu, Kai-Feng Xu, Xian-Yang Zhu, Lei Pan, Zhuo-Li Zhang, Xue-Qin Liu, Yu-Shun Zhang, Xin Jiang, Nazzareno Galiè, None, Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study American Journal of Respiratory and Critical Care Medicine. ,vol. 183, pp. 1723- 1729 ,(2011) , 10.1164/RCCM.201101-0093OC
Jackie D. Corbin, Alfreda Beasley, Mitsi A. Blount, Sharron H. Francis, High lung PDE5: a strong basis for treating pulmonary hypertension with PDE5 inhibitors. Biochemical and Biophysical Research Communications. ,vol. 334, pp. 930- 938 ,(2005) , 10.1016/J.BBRC.2005.06.183
Gary Burgess, Hans Hoogkamer, Lorraine Collings, Jasper Dingemanse, Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil European Journal of Clinical Pharmacology. ,vol. 64, pp. 43- 50 ,(2008) , 10.1007/S00228-007-0408-Z
James R. Klinger, The nitric oxide/cGMP signaling pathway in pulmonary hypertension. Clinics in Chest Medicine. ,vol. 28, pp. 143- 167 ,(2007) , 10.1016/J.CCM.2006.12.002
Gideon A. Paul, J Simon R. Gibbs, Alan R. Boobis, Allifia Abbas, Martin R. Wilkins, Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension. British Journal of Clinical Pharmacology. ,vol. 60, pp. 107- 112 ,(2005) , 10.1111/J.1365-2125.2005.02383.X
Horst Olschewski, Peter Haredza, Burcu Karadaş, Ralph T. Schermuly, Norbert Weissmann, Werner Seeger, Friedrich Grimminger, Hossein A. Ghofrani, Robert Voswinckel, Frank Reichenberger, Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. Journal of the American College of Cardiology. ,vol. 44, pp. 1488- 1496 ,(2004) , 10.1016/J.JACC.2004.06.060
Kazunori AIZAWA, Takeshi HANAOKA, Hiroki KASAI, Kaoru KOGASHI, Setsuo KUMAZAKI, Jun KOYAMA, Hiroshi TSUTSUI, Yoshikazu YAZAKI, Noboru WATANABE, Osamu KINOSHITA, Uichi IKEDA, Long-Term Vardenafil Therapy Improves Hemodynamics in Patients with Pulmonary Hypertension Hypertension Research. ,vol. 29, pp. 123- 128 ,(2006) , 10.1291/HYPRES.29.123
Andrew Jabbour, Anne Keogh, Christopher Hayward, Peter Macdonald, Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation. European Journal of Heart Failure. ,vol. 9, pp. 674- 677 ,(2007) , 10.1016/J.EJHEART.2007.01.008